CERVOMED INC (CRVO) Stock Analyst Earnings Estimates
NASDAQ:CRVO - Nasdaq - US15713L1098 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.145M | 9.738M 36.29% | 6.423M -34.04% | -100.00% | 510K | 18.269M 3,482.16% | 88.416M 383.97% | 540.61M 511.44% | 990.41M 83.20% | |||
| EBITDA YoY % growth | -15.97M -0.13% | N/A 8.03% | N/A -18.75% | -26.622M -52.63% | -66.198M -148.66% | -69.156M -4.47% | -70.38M -1.77% | -49.98M 28.99% | -220.32M -340.82% | 130.05M 159.03% | 414.63M 218.82% | |
| EBIT YoY % growth | -15.97M 0.44% | -7.013M 56.09% | -18.227M -159.91% | -23.075M -26.60% | -47.965M -107.86% | -49.436M -3.07% | -52.02M -5.23% | -26.077M 49.87% | -97.677M -274.57% | 402.51M 512.08% | 889.61M 121.02% | |
| Operating Margin | N/A | -98.15% | -187.17% | -359.26% | N/A | N/A | -10,200.00% | -142.74% | -110.47% | 74.45% | 89.82% | |
| EPS YoY % growth | N/A 14.86% | N/A 82.98% | -2.03 -47.42% | -2.06 -1.70% | -1.81 12.35% | -1.81 0.23% | -1.86 -3.11% | -0.88 52.60% | -2.95 -234.10% | 3.53 219.72% | 7.76 119.80% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.58 -5.34% | -0.33 58.18% | -0.53 5.29% |
| Revenue Q2Q % growth | 1.693M -12.73% | 1.591M -26.41% | -100.00% |
| EBITDA Q2Q % growth | -7.038M -76.92% | -7.854M -26.23% | N/A |
| EBIT Q2Q % growth | -5.722M -6.04% | -5.799M 19.92% | -7.752M -46.18% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.70 -159.26% | -0.64 | -0.06 | -8.93% |
| Q1 2025 Q2Q % growth | -0.56 -36.59% | -0.67 | 0.11 | 16.71% |
| Q4 2024 Q2Q % growth | -0.80 -110.53% | -0.64 | -0.16 | -24.49% |
| Q3 2024 Q2Q % growth | -0.55 21.43% | -0.42 | -0.13 | -30.72% |
| Q2 2024 Q2Q % growth | -0.27 86.28% | -0.31 | 0.04 | 13.49% |
| Q1 2024 Q2Q % growth | -0.41 78.95% | -0.40 | -0.01 | -3.07% |
| Q4 2023 Q2Q % growth | -0.38 83.07% | -0.30 | -0.08 | -28.47% |
| Q3 2023 Q2Q % growth | -0.70 65.94% | -0.97 | 0.27 | 27.76% |
| Q2 2023 Q2Q % growth | 36.29% | -1.97 | % | |
| Q1 2023 Q2Q % growth | 41.50% | -1.95 | % | |
| Q4 2022 Q2Q % growth | 25.20% | -2.24 | % | |
| Q3 2022 Q2Q % growth | -2.06 -37.00% | -3.15 | 1.10 | 34.80% |
| Q2 2022 Q2Q % growth | -3.09 -54.50% | -3.12 | 0.03 | 1.00% |
| Q1 2022 Q2Q % growth | -3.33 -11.00% | -2.68 | -0.65 | -24.37% |
| Q4 2021 Q2Q % growth | -3.00 | -3.06 | 0.06 | 1.96% |
| Q3 2021 Q2Q % growth | -1.50 57.14% | -2.04 | 0.54 | 26.47% |
| Q2 2021 Q2Q % growth | -2.00 33.33% | -2.30 | 0.29 | 12.85% |
| Q1 2021 Q2Q % growth | -3.00 14.29% | -2.30 | -0.71 | -30.72% |
| Q4 2020 Q2Q % growth | -3.00 45.45% | -2.55 | -0.45 | -17.65% |
| Q3 2020 Q2Q % growth | -3.50 88.33% | -2.81 | -0.69 | -24.78% |
| Q2 2020 Q2Q % growth | -3.00 90.48% | -2.81 | -0.19 | -6.95% |
| Q1 2020 Q2Q % growth | -3.50 91.36% | -4.34 | 0.84 | 19.26% |
| Q4 2019 Q2Q % growth | -5.50 | -6.89 | 1.38 | 20.12% |
| Q3 2019 Q2Q % growth | -30.00 | -36.21 | 6.21 | 17.15% |
| Q2 2019 Q2Q % growth | -31.50 | -35.19 | 3.69 | 10.49% |
| Q1 2019 Q2Q % growth | -40.50 | -46.16 | 5.66 | 12.25% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.758M -46.56% | 1.768M | -10.28K | -0.58% |
| Q1 2025 Q2Q % growth | 1.917M -18.32% | 1.756M | 161K | 9.17% |
| Q4 2024 Q2Q % growth | 2.162M -13.19% | 1.782M | 380K | 21.32% |
| Q3 2024 Q2Q % growth | 1.94M 27.13% | 3.128M | -1.188M | -37.98% |
| Q2 2024 Q2Q % growth | 3.289M 5.08% | 2.244M | 1.045M | 46.57% |
| Q1 2024 Q2Q % growth | 2.347M | 1.377M | 970K | 70.44% |
| Q4 2023 Q2Q % growth | 2.491M | 2.04M | 450.58K | 22.09% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.8% | 0% | 0.71% |
| Revenue | 0% | 0.97% | 0% | 12.94% |